Spinal-cord injury

JW McDonald, C Sadowsky - The Lancet, 2002 - thelancet.com
More than a decade ago, spinal-cord injury meant confinement to a wheelchair and a
lifetime of medical comorbidity. The physician's armamentarium of treatments was very …

Beyond the hippocampus and the SVZ: adult neurogenesis throughout the brain

MP Jurkowski, L Bettio, E K. Woo, A Patten… - Frontiers in cellular …, 2020 - frontiersin.org
Convincing evidence has repeatedly shown that new neurons are produced in the
mammalian brain into adulthood. Adult neurogenesis has been best described in the …

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease

C Zuccato, A Ciammola, D Rigamonti, BR Leavitt… - Science, 2001 - science.org
Huntingtin is a 350-kilodalton protein of unknown function that is mutated in Huntington's
disease (HD), a neurodegenerative disorder. The mutant protein is presumed to acquire a …

Molecular mechanisms and potential therapeutical targets in Huntington's disease

C Zuccato, M Valenza, E Cattaneo - Physiological reviews, 2010 - journals.physiology.org
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG repeat
expansion in the gene encoding for huntingtin protein. A lot has been learned about this …

Stem cell therapy for human neurodegenerative disorders–how to make it work

O Lindvall, Z Kokaia, A Martinez-Serrano - Nature medicine, 2004 - nature.com
Recent progress shows that neurons suitable for transplantation can be generated from
stem cells in culture, and that the adult brain produces new neurons from its own stem cells …

Current and possible future therapeutic options for Huntington's disease

MW Ferguson, CJ Kennedy… - Journal of central …, 2022 - journals.sagepub.com
Huntington's disease (HD) is an autosomal neurodegenerative disease that is characterized
by an excessive number of CAG trinucleotide repeats within the huntingtin gene (HTT). HD …

Clinical features of Huntington's disease

R Ghosh, SJ Tabrizi - Polyglutamine disorders, 2018 - Springer
Huntington's disease (HD) is the most common monogenic neurodegenerative disease and
the commonest genetic dementia in the developed world. With autosomal dominant …

Stem cell‐based cell therapy in neurological diseases: a review

SU Kim, J De Vellis - Journal of neuroscience research, 2009 - Wiley Online Library
Human neurological disorders such as Parkinson's disease, Huntington's disease,
amyotrophic lateral sclerosis (ALS), Alzheimer's disease, multiple sclerosis (MS), stroke, and …

Brain plasticity: from pathophysiological mechanisms to therapeutic applications

H Duffau - Journal of clinical neuroscience, 2006 - Elsevier
Cerebral plasticity, which is the dynamic potential of the brain to reorganize itself during
ontogeny, learning, or following damage, has been widely studied in the last decade, in …

Current progress in the derivation and therapeutic application of neural stem cells

Y Tang, P Yu, L Cheng - Cell death & disease, 2017 - nature.com
Neural stem cells (NSCs) have a unique role in neural regeneration. Cell therapy based on
NSC transplantation is a promising tool for the treatment of nervous system diseases …